Shanghai RAAS Blood Products Co., Ltd. (SHE:002252)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Production and Sale of Blood Products			7.96B	6.57B	4.29B	2.76B	2.58B
Production and Sale of Blood Products Growth			21.27%	53.16%	55.31%	6.81%	43.26%
Unallocated Other Operations			-	-	-	994.92K	234.77K
Unallocated Other Operations Growth			-	-	-	323.79%	-
Total			7.96B	6.57B	4.29B	2.76B	2.58B
Total Growth			21.27%	53.16%	55.26%	6.84%	43.27%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
East China			2.98B	2.41B	1.54B	998.73M	948.55M
East China Growth			23.53%	56.41%	54.31%	5.29%	48.90%
Southern China			1.86B	1.59B	1.03B	652.64M	656.14M
Southern China Growth			16.35%	54.14%	58.53%	-0.53%	44.62%
Northern China			1.93B	1.54B	897.27M	682.55M	565.37M
Northern China Growth			25.44%	71.45%	31.46%	20.72%	43.07%
Northeast China Region			298.30M	251.66M	172.13M	87.75M	92.49M
Northeast China Region Growth			18.53%	46.20%	96.15%	-5.12%	-18.05%
Southwest Region			516.08M	323.00M	202.02M	190.55M	216.06M
Southwest Region Growth			59.78%	59.89%	6.02%	-11.81%	52.88%
Northwestern Region			363.76M	279.67M	167.32M	54.62M	44.85M
Northwestern Region Growth			30.07%	67.14%	206.31%	21.78%	24.06%
Export			22.81M	169.23M	273.16M	94.84M	61.52M
Export Growth			-86.52%	-38.05%	188.03%	54.17%	119.85%
Total			7.96B	6.57B	4.29B	2.76B	2.58B
Total Growth			21.27%	53.16%	55.26%	6.84%	43.27%

Source: S&P Global Market Intelligence.